Midori USA
Innovative microbiome technology enhancing sustainability and economics in animal farming without antibiotics.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
* | $63.0m Valuation: $102m | Acquisition | |
| Total Funding | 000k | ||
Related Content
Midori Animal Health is at the forefront of revolutionizing the animal microbiome to enhance the economics and sustainability of poultry, swine, ruminant, and aquaculture farming. Founded in 2009 and based in Cambridge, MA, Midori is a Flagship Pioneering Company. The company leverages cutting-edge microbiome technology to improve the quality and sustainability of animal protein production, reducing the need for antibiotics and other drugs. This innovative approach not only benefits production animals but also promises better health, nutrition, and quality of life for companion animals by harnessing the functional potential of the animal microbiome.
Midori operates in the animal health and nutrition market, serving clients in the agricultural and pet care sectors. The business model focuses on developing and commercializing non-drug products that optimize gut health and functionality, thereby improving animal growth, metabolism, feed utilization, immune health, body composition, and behavior. Revenue is generated through the sale of these microbiome-based products to farmers and pet owners who seek sustainable and effective solutions for animal health.
Keywords: microbiome, animal health, sustainability, poultry, swine, ruminant, aquaculture, antibiotics-free, gut health, companion animals.